Showing results (111-120 of 117) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 117 results.
Translational Psychiatry|June 24, 2026
Mechanistic insights toward dissociating therapeutic from psychedelic effects: bridging the gap between psychedelic research and mental health careMauro Pettorruso, Giacomo d'Andrea, Antonio Inserra, et al.
International Journal of Molecular Sciences|February 25, 2023
The Effects of Peripubertal THC Exposure in Neurodevelopmental Rat Models of PsychopathologyMartina Di Bartolomeo, Tibor Stark, Serena Di Martino, et al.
Frontiers in Psychiatry|November 17, 2025
Bipolar disorder integrative staging: incorporating biomarkers into progression across stages (BOARDING-PASS) - rationale and designNicolaja Girone, Laura Cremaschi, Monica Macellaro, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 23, 2012
Selective DNA methylation of BDNF promoter in bipolar disorder: differences among patients with BDI and BDIIClaudio D'Addario, Bernardo Dell'Osso, Maria Carlotta Palazzo, et al.
Pharmacological Research|December 7, 2020
Crosstalk between the transcriptional regulation of dopamine D2 and cannabinoid CB1 receptors in schizophrenia: Analyses in patients and in perinatal Δ9-tetrahydrocannabinol-exposed ratsMartina Di Bartolomeo, Tibor Stark, Oriana Maria Maurel, et al.
Neuropharmacology|November 30, 2018
Peripubertal cannabidiol treatment rescues behavioral and neurochemical abnormalities in the MAM model of schizophreniaTibor Stark, Jana Ruda-Kucerova, Fabio Arturo Iannotti, et al.
Biochemical Pharmacology|May 4, 2020
Altered dopamine D3 receptor gene expression in MAM model of schizophrenia is reversed by peripubertal cannabidiol treatmentTibor Stark, Martina Di Bartolomeo, Roberta Di Marco, et al.
Pageof 12